 1. That treatment with the bisphosphonate, zoledronate, at the time of liver transplantation and at 1 month post-transplantation will prevent the early transplant-related bone loss measured by bone densitometry and biochemical bone markers at 3 months seen in patients who are not treated with a bisphosphonate 